Skip to main content

Table 3 Univariable analysis of risk of mortality as a function of patient comorbidities and characteristics

From: Spectrum of disease in HIV-positive patients presenting to a tertiary care hospital: a retrospective, cross-sectional review in Kumasi, Ghana

  Valid N Hazard Ratio 95% Confidence Interval p
Lower Upper
Age (per 5 year increase) 244 1.105 0.999 1.222 .052
Male vs Female 245 1.475 0.963 2.258 .07
Referred to KATH: Yes vs No 189 0.828 0.514 1.333 .44
Reason for Admission (Yes vs No)
 Constitutional symptoms 240 0.832 0.512 1.353 .46
 Neurological symptoms 239 2.113 1.362 3.279 .001
 Pulmonary symptoms 240 0.892 0.566 1.407 .62
 Cardiac symptoms 240 0.871 0.433 1.753 .70
 Gastrointestinal symptoms 241 0.538 0.301 0.962 .04
 Other reason for admission 243 1.576 0.783 3.171 .20
Months since HIV diagnosis (per 1 month increase) 205 1.004 0.998 1.009 .18
New vs Known HIV diagnosis 244 0.866 0.554 1.353 .53
HAART: Yes vs No 237 0.969 0.625 1.502 .89
Prophylaxis Medication: Yes vs No 235 1.146 0.675 1.945 .61
HgB (per 1 unit increase) 230 0.996 0.964 1.029 .81
PLT (per 5 unit increase) 224 1.003 0.996 1.010 .43
Febrile Exam: Yes vs No 232 1.342 0.845 2.132 .21
Clinical Stage (vs Stage 0–2) 244     .12
 Stage 3   2.937 0.707 12.191 .14
 Stage 4   3.794 0.918 15.680 .07
Final Diagnoses (Yes vs No)
 ICSOL 245 1.724 1.084 2.742 .02
 ICSOL with CT 56 0.402 0.162 1.000 .0501
 CT-suggestive Toxoplasmosis 245 0.553 0.174 1.756 .32
 Pulmonary TB 245 1.041 0.670 1.619 .86
 Encephalopathy 244 2.133 0.927 4.909 .07
 Pneumonia 245 1.787 1.089 2.931 .02
 Gastroenteritis 245 1.217 0.586 2.527 .60
 Candidiasis 245 0.939 0.536 1.643 .82
 Pleural Effusion 245 0.735 0.317 1.701 .47
 HTN 245 0.610 0.246 1.511 .29
 Anemia 245 1.139 0.744 1.743 .55
 HIV-Associated nephropathy 245 1.331 0.487 3.640 .58
 Hepatitis B 245 1.175 0.511 2.702 .70
 Diarrhea 245 1.001 0.404 2.478 .99